Aldo Quattrone
Aldo Quattrone
Email verificata su unicz.it
TitoloCitata daAnno
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
S ZŘchner, IV Mersiyanova, M Muglia, N Bissar-Tadmouri, J Rochelle, ...
Nature genetics 36 (5), 449, 2004
13612004
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease
E Sidransky, MA Nalls, JO Aasly, J Aharon-Peretz, G Annesi, ER Barbosa, ...
New England Journal of Medicine 361 (17), 1651-1661, 2009
11182009
Collaborative analysis of α-synuclein gene promoter variability and Parkinson disease
DM Maraganore, M De Andrade, A Elbaz, MJ Farrer, JP Ioannidis, ...
Jama 296 (6), 661-670, 2006
4762006
The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy
M De Fusco, A Becchetti, A Patrignani, G Annesi, A Gambardella, ...
Nature genetics 26 (3), 275, 2000
4702000
Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2
A Bolino, M Muglia, FL Conforti, E LeGuern, MAM Salih, DM Georgiou, ...
Nature genetics 25 (1), 17, 2000
4692000
Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders
B Jones, EL Jones, SA Bonney, HN Patel, AR Mensenkamp, ...
Nature genetics 34 (1), 29, 2003
3442003
UCHL1 is a Parkinson's disease susceptibility gene
DM Maraganore, TG Lesnick, A Elbaz, MC Chartier‐Harlin, T Gasser, ...
Annals of neurology 55 (4), 512-521, 2004
2622004
Manometry combined with cervical puncture in idiopathic intracranial hypertension
JO King, PJ Mitchell, KR Thomson, BM Tress
Neurology 58 (1), 26-30, 2002
2532002
MR Imaging Index for Differentiation of Progressive Supranuclear Palsy from Parkinson Disease and the Parkinson Variant of Multiple System Atrophy1
A Quattrone, G Nicoletti, D Messina, F Fera, F Condino, P Pugliese, ...
Radiology 246 (1), 214-221, 2008
2512008
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies
MA Nalls, R Duran, G Lopez, M Kurzawa-Akanbi, IG McKeith, ...
JAMA neurology 70 (6), 727-735, 2013
2202013
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy
G Nicoletti, R Lodi, F Condino, C Tonon, F Fera, E Malucelli, D Manners, ...
Brain 129 (10), 2679-2687, 2006
2142006
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis
L Morgante, A Epifanio, E Spina, M Zappia, AE Di Rosa, R Marconi, ...
Clinical neuropharmacology 27 (4), 153-156, 2004
2022004
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
OA Ross, AI Soto-Ortolaza, MG Heckman, JO Aasly, N Abahuni, G Annesi, ...
The Lancet Neurology 10 (10), 898-908, 2011
2002011
Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study
M Zappia, G Annesi, G Nicoletti, G Arabia, F Annesi, D Messina, ...
Archives of neurology 62 (4), 601-605, 2005
1822005
Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial
D Pareyson, MM Reilly, A Schenone, GM Fabrizi, T Cavallaro, L Santoro, ...
The Lancet Neurology 10 (4), 320-328, 2011
1752011
Identification of an Nav1. 1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures
M Mantegazza, A Gambardella, R Rusconi, E Schiavon, F Annesi, ...
Proceedings of the National Academy of Sciences 102 (50), 18177-18182, 2005
1702005
Monoamine oxidase-a genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity
L Passamonti, F Fera, A Magariello, A Cerasa, MC Gioia, M Muglia, ...
Biological psychiatry 59 (4), 334-340, 2006
1682006
Brain atrophy and lesion load in a large population of patients with multiple sclerosis
G Tedeschi, L Lavorgna, P Russo, A Prinster, D Dinacci, G Savettieri, ...
Neurology 65 (2), 280-285, 2005
1672005
Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5‐hydroxytryptaminergic neurones. Studies with fenfluramine.
A Quattrone, G Tedeschi, U Aguglia, F Scopacasa, GF Direnzo, ...
British journal of clinical pharmacology 16 (5), 471-475, 1983
1661983
DJ‐1 mutations and parkinsonism‐dementia‐amyotrophic lateral sclerosis complex
G Annesi, G Savettieri, P Pugliese, M D'Amelio, P Tarantino, P Ragonese, ...
Annals of Neurology: Official Journal of the American Neurologicalá…, 2005
1642005
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20